According to this latest study, the 2021 growth of Vaccine for Influenza will have significant change from previous year. By the most conservative estimates of global Vaccine for Influenza market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine for Influenza market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Influenza market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

For Children (6 months to 3 years)

For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sanofi

CSL

GSK

Mylan

Hulan Bio

AstraZeneca

CCBIO

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine for Influenza Consumption 2016-2026

2.1.2 Vaccine for Influenza Consumption CAGR by Region

2.2 Vaccine for Influenza Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Vaccine for Influenza Sales by Type

2.3.1 Global Vaccine for Influenza Sales Market Share by Type (2016-2021)

2.3.2 Global Vaccine for Influenza Revenue and Market Share by Type (2016-2021)

2.3.3 Global Vaccine for Influenza Sale Price by Type (2016-2021)

2.4 Vaccine for Influenza Segment by Application

2.4.1 For Children (6 months to 3 years)

2.4.2 For Adults and Children over 3 years

2.5 Vaccine for Influenza Sales by Application

2.5.1 Global Vaccine for Influenza Sale Market Share by Application (2016-2021)

2.5.2 Global Vaccine for Influenza Revenue and Market Share by Application (2016-2021)

2.5.3 Global Vaccine for Influenza Sale Price by Application (2016-2021)

3 Global Vaccine for Influenza by Company

3.1 Global Vaccine for Influenza Sales Market Share by Company

3.1.1 Global Vaccine for Influenza Sales by Company (2019-2021)

3.1.2 Global Vaccine for Influenza Sales Market Share by Company (2019-2021)

3.2 Global Vaccine for Influenza Revenue Market Share by Company

3.2.1 Global Vaccine for Influenza Revenue by Company (2019-2021)

3.2.2 Global Vaccine for Influenza Revenue Market Share by Company (2019-2021)

3.3 Global Vaccine for Influenza Sale Price by Company

3.4 Global Manufacturers Vaccine for Influenza Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccine for Influenza Product Location Distribution

3.4.2 Players Vaccine for Influenza Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Vaccine for Influenza by Region

4.1 Global Vaccine for Influenza by Region

4.1.1 Global Vaccine for Influenza Sales by Region

4.1.2 Global Vaccine for Influenza Revenue by Region

4.2 Americas Vaccine for Influenza Sales Growth

4.3 APAC Vaccine for Influenza Sales Growth

4.4 Europe Vaccine for Influenza Sales Growth

4.5 Middle East & Africa Vaccine for Influenza Sales Growth

5 Americas

5.1 Americas Vaccine for Influenza Sales by Country

5.1.1 Americas Vaccine for Influenza Sales by Country (2016-2021)

5.1.2 Americas Vaccine for Influenza Revenue by Country (2016-2021)

5.2 Americas Vaccine for Influenza Sales by Type

5.3 Americas Vaccine for Influenza Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine for Influenza Sales by Region

6.1.1 APAC Vaccine for Influenza Sales by Region (2016-2021)

6.1.2 APAC Vaccine for Influenza Revenue by Region (2016-2021)

6.2 APAC Vaccine for Influenza Sales by Type

6.3 APAC Vaccine for Influenza Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Vaccine for Influenza by Country

7.1.1 Europe Vaccine for Influenza Sales by Country (2016-2021)

7.1.2 Europe Vaccine for Influenza Revenue by Country (2016-2021)

7.2 Europe Vaccine for Influenza Sales by Type

7.3 Europe Vaccine for Influenza Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine for Influenza by Country

8.1.1 Middle East & Africa Vaccine for Influenza Sales by Country (2016-2021)

8.1.2 Middle East & Africa Vaccine for Influenza Revenue by Country (2016-2021)

8.2 Middle East & Africa Vaccine for Influenza Sales by Type

8.3 Middle East & Africa Vaccine for Influenza Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Vaccine for Influenza Distributors

10.3 Vaccine for Influenza Customer

11 Global Vaccine for Influenza Market Forecast

11.1 Global Vaccine for Influenza Forecast by Region

11.1.1 Global Vaccine for Influenza Forecast by Regions (2021-2026)

11.2.2 Global Vaccine for Influenza Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Vaccine for Influenza Forecast by Type

11.7 Global Vaccine for Influenza Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Sanofi Company Information

12.1.2 Sanofi Vaccine for Influenza Product Offered

12.1.3 Sanofi Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 CSL

12.2.1 CSL Company Information

12.2.2 CSL Vaccine for Influenza Product Offered

12.2.3 CSL Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 CSL Main Business Overview

12.2.5 CSL Latest Developments

12.3 GSK

12.3.1 GSK Company Information

12.3.2 GSK Vaccine for Influenza Product Offered

12.3.3 GSK Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 GSK Main Business Overview

12.3.5 GSK Latest Developments

12.4 Mylan

12.4.1 Mylan Company Information

12.4.2 Mylan Vaccine for Influenza Product Offered

12.4.3 Mylan Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Mylan Main Business Overview

12.4.5 Mylan Latest Developments

12.5 Hulan Bio

12.5.1 Hulan Bio Company Information

12.5.2 Hulan Bio Vaccine for Influenza Product Offered

12.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Hulan Bio Main Business Overview

12.5.5 Hulan Bio Latest Developments

12.6 AstraZeneca

12.6.1 AstraZeneca Company Information

12.6.2 AstraZeneca Vaccine for Influenza Product Offered

12.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 AstraZeneca Main Business Overview

12.6.5 AstraZeneca Latest Developments

12.7 CCBIO

12.7.1 CCBIO Company Information

12.7.2 CCBIO Vaccine for Influenza Product Offered

12.7.3 CCBIO Vaccine for Influenza Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 CCBIO Main Business Overview

12.7.5 CCBIO Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Vaccine for Influenza Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Trivalent Influenza Vaccine

Table 3. Major Players of Quadrivalent Influenza Vaccine

Table 4. Global Vaccine for Influenza Sales by Type (2016-2021) & (K Units)

Table 5. Global Vaccine for Influenza Sales Market Share by Type (2016-2021)

Table 6. Global Vaccine for Influenza Revenue by Type (2016-2021) & ($ million)

Table 7. Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)

Table 8. Global Vaccine for Influenza Sale Price by Type (2016-2021)

Table 9. Global Vaccine for Influenza Sales by Application (2016-2021) & (K Units)

Table 10. Global Vaccine for Influenza Sales Market Share by Application (2016-2021)

Table 11. Global Vaccine for Influenza Value by Application (2016-2021)

Table 12. Global Vaccine for Influenza Revenue Market Share by Application (2016-2021)

Table 13. Global Vaccine for Influenza Sale Price by Application (2016-2021)

Table 14. Global Vaccine for Influenza Sales by Company (2019-2021) & (K Units)

Table 15. Global Vaccine for Influenza Sales Market Share by Company (2019-2021)

Table 16. Global Vaccine for Influenza Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Vaccine for Influenza Revenue Market Share by Company (2019-2021)

Table 18. Global Vaccine for Influenza Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Vaccine for Influenza Producing Area Distribution and Sales Area

Table 20. Players Vaccine for Influenza Products Offered

Table 21. Vaccine for Influenza Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Vaccine for Influenza Sales by Region (2016-2021) (K Units)

Table 25. Global Vaccine for Influenza Sales Market Share by Region (2016-2021)

Table 26. Global Vaccine for Influenza Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Vaccine for Influenza Revenue Market Share by Region (2016-2021)

Table 28. Americas Vaccine for Influenza Sales by Country (2016-2021) & (K Units)

Table 29. Americas Vaccine for Influenza Sales Market Share by Country (2016-2021)

Table 30. Americas Vaccine for Influenza Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Vaccine for Influenza Revenue Market Share by Country (2016-2021)

Table 32. Americas Vaccine for Influenza Sales by Type (2016-2021) & (K Units)

Table 33. Americas Vaccine for Influenza Sales Market Share by Type (2016-2021)

Table 34. Americas Vaccine for Influenza Sales by Application (2016-2021) & (K Units)

Table 35. Americas Vaccine for Influenza Sales Market Share by Application (2016-2021)

Table 36. APAC Vaccine for Influenza Sales by Region (2016-2021) & (K Units)

Table 37. APAC Vaccine for Influenza Sales Market Share by Region (2016-2021)

Table 38. APAC Vaccine for Influenza Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Vaccine for Influenza Revenue Market Share by Region (2016-2021)

Table 40. APAC Vaccine for Influenza Sales by Type (2016-2021) & (K Units)

Table 41. APAC Vaccine for Influenza Sales Market Share by Type (2016-2021)

Table 42. APAC Vaccine for Influenza Sales by Application (2016-2021) & (K Units)

Table 43. APAC Vaccine for Influenza Sales Market Share by Application (2016-2021)

Table 44. Europe Vaccine for Influenza Sales by Country (2016-2021) & (K Units)

Table 45. Europe Vaccine for Influenza Sales Market Share by Country (2016-2021)

Table 46. Europe Vaccine for Influenza Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Vaccine for Influenza Revenue Market Share by Country (2016-2021)

Table 48. Europe Vaccine for Influenza Sales by Type (2016-2021) & (K Units)

Table 49. Europe Vaccine for Influenza Sales Market Share by Type (2016-2021)

Table 50. Europe Vaccine for Influenza Sales by Application (2016-2021) & (K Units)

Table 51. Europe Vaccine for Influenza Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Vaccine for Influenza Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Vaccine for Influenza Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Vaccine for Influenza Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Vaccine for Influenza Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Vaccine for Influenza Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Vaccine for Influenza Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Vaccine for Influenza Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Vaccine for Influenza

Table 61. Key Application and Potential Industries of Vaccine for Influenza

Table 62. Key Challenges of Vaccine for Influenza

Table 63. Key Trends of Vaccine for Influenza

Table 64. Vaccine for Influenza Distributors List

Table 65. Vaccine for Influenza Customer List

Table 66. Global Vaccine for Influenza Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Vaccine for Influenza Consumption Market Forecast by Region

Table 68. Global Vaccine for Influenza Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Vaccine for Influenza Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Vaccine for Influenza Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Vaccine for Influenza Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Vaccine for Influenza Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Vaccine for Influenza Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Vaccine for Influenza Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Vaccine for Influenza Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Vaccine for Influenza Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Vaccine for Influenza Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Vaccine for Influenza Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Vaccine for Influenza Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Vaccine for Influenza Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Vaccine for Influenza Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Vaccine for Influenza Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2021-2026)

Table 86. Sanofi Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 87. Sanofi Vaccine for Influenza Product Offered

Table 88. Sanofi Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Sanofi Main Business

Table 90. Sanofi Latest Developments

Table 91. CSL Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 92. CSL Vaccine for Influenza Product Offered

Table 93. CSL Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. CSL Main Business

Table 95. CSL Latest Developments

Table 96. GSK Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 97. GSK Vaccine for Influenza Product Offered

Table 98. GSK Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. GSK Main Business

Table 100. GSK Latest Developments

Table 101. Mylan Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 102. Mylan Vaccine for Influenza Product Offered

Table 103. Mylan Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Mylan Main Business

Table 105. Mylan Latest Developments

Table 106. Hulan Bio Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 107. Hulan Bio Vaccine for Influenza Product Offered

Table 108. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Hulan Bio Main Business

Table 110. Hulan Bio Latest Developments

Table 111. AstraZeneca Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 112. AstraZeneca Vaccine for Influenza Product Offered

Table 113. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. AstraZeneca Main Business

Table 115. AstraZeneca Latest Developments

Table 116. CCBIO Basic Information, Vaccine for Influenza Manufacturing Base, Sales Area and Its Competitors

Table 117. CCBIO Vaccine for Influenza Product Offered

Table 118. CCBIO Vaccine for Influenza Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. CCBIO Main Business

Table 120. CCBIO Latest Developments

List of Figures

Figure 1. Picture of Vaccine for Influenza

Figure 2. Vaccine for Influenza Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccine for Influenza Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Vaccine for Influenza Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Vaccine for Influenza Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Vaccine for Influenza Sales Market Share by Type in 2020

Figure 12. Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)

Figure 13. Vaccine for Influenza Consumed in For Children (6 months to 3 years)

Figure 14. Global Vaccine for Influenza Market: For Children (6 months to 3 years) (2016-2021) & (K Units)

Figure 15. Vaccine for Influenza Consumed in For Adults and Children over 3 years

Figure 16. Global Vaccine for Influenza Market: For Adults and Children over 3 years (2016-2021) & (K Units)

Figure 17. Global Vaccine for Influenza Sales Market Share by Application (2016-2021)

Figure 18. Global Vaccine for Influenza Revenue Market Share by Application in 2020

Figure 19. Vaccine for Influenza Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Vaccine for Influenza Revenue Market Share by Company in 2020

Figure 21. Global Vaccine for Influenza Sales Market Share by Regions (2016-2021)

Figure 22. Global Vaccine for Influenza Revenue Market Share by Region in 2020

Figure 23. Americas Vaccine for Influenza Sales 2016-2021 (K Units)

Figure 24. Americas Vaccine for Influenza Revenue 2016-2021 ($ Millions)

Figure 25. APAC Vaccine for Influenza Sales 2016-2021 (K Units)

Figure 26. APAC Vaccine for Influenza Revenue 2016-2021 ($ Millions)

Figure 27. Europe Vaccine for Influenza Sales 2016-2021 (K Units)

Figure 28. Europe Vaccine for Influenza Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Vaccine for Influenza Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa Vaccine for Influenza Revenue 2016-2021 ($ Millions)

Figure 31. Americas Vaccine for Influenza Sales Market Share by Country in 2020

Figure 32. Americas Vaccine for Influenza Revenue Market Share by Country in 2020

Figure 33. Americas Vaccine for Influenza Sales Market Share by Type in 2020

Figure 34. Americas Vaccine for Influenza Sales Market Share by Application in 2020

Figure 35. United States Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Vaccine for Influenza Sales Market Share by Region in 2020

Figure 40. APAC Vaccine for Influenza Revenue Market Share by Regions in 2020

Figure 41. APAC Vaccine for Influenza Sales Market Share by Type in 2020

Figure 42. APAC Vaccine for Influenza Sales Market Share by Application in 2020

Figure 43. China Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Vaccine for Influenza Sales Market Share by Country in 2020

Figure 50. Europe Vaccine for Influenza Revenue Market Share by Country in 2020

Figure 51. Europe Vaccine for Influenza Sales Market Share by Type in 2020

Figure 52. Europe Vaccine for Influenza Sales Market Share by Application in 2020

Figure 53. Germany Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Vaccine for Influenza Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Vaccine for Influenza Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Vaccine for Influenza Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Vaccine for Influenza Sales Market Share by Application in 2020

Figure 62. Egypt Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Vaccine for Influenza Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles